Futura Medical (LON:FUM) Trading 15.7% Higher – Here’s Why

Shares of Futura Medical plc (LON:FUM) shot up 15.7% during mid-day trading on Thursday . The company traded as high as GBX 1.44 and last traded at GBX 1.44. 366,663 shares were traded during trading, a decline of 97% from the average session volume of 10,885,366 shares. The stock had previously closed at GBX 1.25.

Futura Medical Stock Down 2.8%

The company has a 50-day moving average price of GBX 1.43 and a 200-day moving average price of GBX 5.57. The company has a market capitalization of £4.07 million, a price-to-earnings ratio of -0.58 and a beta of 1.25.

Insider Transactions at Futura Medical

In other Futura Medical news, insider Harmesh Suniara sold 4,441,678 shares of the firm’s stock in a transaction that occurred on Thursday, November 13th. The stock was sold at an average price of GBX 2, for a total value of £88,833.56. 25.86% of the stock is owned by company insiders.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.